Advanced search
Publication Cover
Expert Review of Vaccines Volume 14, 2015 - Issue 4
Submit an article Journal homepage
494
Views
17
CrossRef citations to date
0
Altmetric
Vaccine Profile

Neisseria meningitidis serogroup B bivalent factor H binding protein vaccine

Nathan James BrendishNIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Mailpoint 218, West Wing, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
&
Robert Charles ReadAcademic Unit of Clinical and Experimental Sciences and Institute for Life Sciences, University Hospital Southampton NHS Foundation Trust, University of Southampton, and NIHR Respiratory Biomedical Research Unit, Mailpoint 814, South Academic Block, Southampton General Hospital, Southampton, SO16 6YD, UKCorrespondence[email protected]
Pages 493-503 | Published online: 23 Feb 2015

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Daniela Toneatto, Mariagrazia Pizza, Vega Masignani & Rino Rappuoli. (2017) Emerging experience with meningococcal serogroup B protein vaccines. Expert Review of Vaccines 16:5, pages 433-451.
Read now
Jamie Findlow. (2016) Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?. Human Vaccines & Immunotherapeutics 12:1, pages 235-238.
Read now
Jan T Poolman & Peter Richmond. (2015) Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness. Expert Review of Vaccines 14:9, pages 1277-1287.
Read now

Articles from other publishers (14)

David S. Stephens, Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2023. Plotkin's Vaccines. Plotkin's Vaccines 690 710.e7 .
Ala-Eddine Deghmane, Samy Taha & Muhamed-Kheir Taha. (2022) La vaccination contre les infections invasives à méningocoque. Revue Francophone des Laboratoires 2022:540, pages 53-60.
Crossref
Luke Smithers, Samir Olatunji & Martin Caffrey. (2021) Bacterial Lipoprotein Posttranslational Modifications. New Insights and Opportunities for Antibiotic and Vaccine Development. Frontiers in Microbiology 12.
Crossref
Saul N. Faust, Diane Gbesemete & Robert S. Heyderman. 2019. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology 434 455 .
Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2018. Plotkin's Vaccines. Plotkin's Vaccines 644 662.e6 .
Ian M. Feavers & Martin C. J. Maiden. (2017) Recent Progress in the Prevention of Serogroup B Meningococcal Disease. Clinical and Vaccine Immunology 24:5.
Crossref
Peter Michael Moyle. (2017) Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines. Biotechnology Advances 35:3, pages 375-389.
Crossref
Heidi M. Soeters, Melissa Whaley, Nicole Alexander-Scott, Koren V. Kanadanian, Jessica R. MacNeil, Stacey W. Martin, Lucy A. McNamara, Kenneth Sicard, Cynthia Vanner, Jeni Vuong, Xin Wang, Utpala Bandy & Manisha Patel. (2017) Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College—Rhode Island, 2015–2016. Clinical Infectious Diseases 64:8, pages 1115-1122.
Crossref
Fenglin Shi, Aiyu Zhang, Bingqing Zhu, Yuan Gao, Li Xu, Yixing Li, Zundong Yin, Junhong Li, Na Xie & Zhujun Shao. (2017) Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China. Vaccine 35:18, pages 2343-2350.
Crossref
M. Sadarangani & A.J. Pollard. (2016) Can we control all-cause meningococcal disease in Europe?. Clinical Microbiology and Infection 22, pages S103-S112.
Crossref
Nicole E Basta & Hannah Christensen. (2016) 4CMenB vaccine effectiveness: reasons for optimism. The Lancet 388:10061, pages 2719-2721.
Crossref
Patrick L. Ahl, Christopher Mensch, Binghua Hu, Heidi Pixley, Lan Zhang, Lance Dieter, Ryann Russell, William J. Smith, Craig Przysiecki, Mike Kosinski & Jeffrey T. Blue. (2016) Accelerating Vaccine Formulation Development Using Design of Experiment Stability Studies. Journal of Pharmaceutical Sciences 105:10, pages 3046-3056.
Crossref
Héloïse Lecocq, Isabelle Parent du Châtelet, Muhamed-Kheir Taha, Daniel Lévy-Bruhl & Benoit Dervaux. (2016) Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France. Vaccine 34:19, pages 2240-2250.
Crossref
Andrew R Gorringe. (2016) The difficult road to new vaccines for pertussis and serogroup B meningococcal disease. Journal of Chemical Technology & Biotechnology 91:1, pages 9-15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.